STAT+: House committees strike deal on health transparency, PBM reform package
WASHINGTON — Republicans on three key House committees have reconciled their differing legislative packages to…
Category: PBMs
STAT+: Blue Shield of California overhauls drug pricing operation — by adding more vendors
Blue Shield of California, a health insurance company that covers almost 5 million people, is…
STAT+: Health care CEOs hauled in $4 billion last year as inflation pinched workers, analysis shows
The health care industry didn’t just provide a safe haven for jittery stock investors in…
Opinion: STAT+: What Mark Cuban gets wrong about prescription drugs
Mark Cuban, the Dallas Mavericks owner and “Shark Tank” star, has been making headlines recently…
STAT+: Senate panel advances PBM reform — but sidesteps anything controversial
WASHINGTON — Senators on the Finance Committee on Wednesday nearly unanimously passed a bill to…
STAT+: Congress’s PBM reforms won’t end America’s drug pricing woes. Here’s what they would do
WASHINGTON — Lawmakers in Congress generally agree that there’s something very broken with the way America…
STAT+: DOJ, FTC primed for more aggressive scrutiny of health care mergers
Health care companies trying to merge can expect tougher policing from the top federal antitrust…
STAT+: Conservative group opposing PBM reform spends record number on lobbying
WASHINGTON — A conservative group advocating against changing how pharmacy middlemen operate spent more than…
Listen: Messy PBM conflicts, debatable vaccines, & the future of flu season
Who’s watching the drug price watchmen? Are RSV vaccines too expensive? And is it finally…
Sen. Grassley calls on GOP leaders to rally support for PBM reforms
WASHINGTON — Republican Sen. Chuck Grassley wants to see his party’s leadership turn up the…
STAT+: ‘It’s beyond unethical’: Opaque conflicts of interest permeate prescription drug benefits
Employers across the country — from big names like Boeing and UPS to local school…
STAT+: Key House Republican escalates rhetoric against PBMs
WASHINGTON — A key House Republican ramped up his criticism of pharmacy benefit managers Tuesday,…
STAT+: CVS warns PBM reforms ‘could lead to higher costs’
As Congress considers wide-ranging reforms to pharmacy benefit managers, a top executive at CVS Health,…
STAT+: Congress highlighted a chemo drug’s price to blast PBMs — but it’s not a PBM issue
WASHINGTON — Congress blasted drug middlemen at a hearing Tuesday, with multiple lawmakers pointing to…
STAT+: Senate panel passes a suite of drug pricing bills — but fails to advance one major PBM reform
WASHINGTON – The Senate health committee on Thursday passed a package of bills aimed at…
STAT+: Insulin makers, PBMs echo old finger-pointing in Senate hearing
A Senate hearing on high insulin costs billed as a blockbuster showdown with drugmakers and…
STAT+: Q&A: Sen. Sanders on insulin costs and his committee’s generic drug kerfuffle
WASHINGTON — Wednesday’s Senate hearing on high costs for insulin “is not the end” of…
STAT+: Disagreements and digs upend an otherwise bipartisan hearing on PBM reform
WASHINGTON — The first Senate health committee markup under Chairman Bernie Sanders (I-Vt.) and ranking…
STAT+: Another powerful congressional committee is ready to take on PBMs
WASHINGTON — House Oversight Committee Chairman James Comer plans to hold a hearing on the…
STAT+: Powerful Senate duo drops a bipartisan PBM reform plan
WASHINGTON — The chair and ranking Republican on the Senate Finance Committee on Thursday unveiled…
STAT+: Pharmalittle: Merck is eyeing Seagen to beef up its cancer drug portfolio; Lawmakers want GAO to probe PBMs
Good morning, everyone, and welcome to another working week, although today is actually a holiday…